Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation.

2.50
Hdl Handle:
http://hdl.handle.net/10541/620390
Title:
Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation.
Authors:
Zagadailov, E; Corman, S; Hagan, M; Chirikov, V; Johnson, C; Macahilig, C; Sea, B; Dalal, M; Brockelmann, P; Illidge, Timothy M ( 0000-0003-3191-7324 )
Affiliation:
Millennium Pharmaceuticals, Inc., Cambridge, MA, USA
Citation:
Real-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation. 2016, 101(s5): 51 Haematologica
Journal:
Haematologica
Issue Date:
24-May-2017
URI:
http://hdl.handle.net/10541/620390
Type:
Meetings and Proceedings
Language:
en
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorZagadailov, Een
dc.contributor.authorCorman, Sen
dc.contributor.authorHagan, Men
dc.contributor.authorChirikov, Ven
dc.contributor.authorJohnson, Cen
dc.contributor.authorMacahilig, Cen
dc.contributor.authorSea, Ben
dc.contributor.authorDalal, Men
dc.contributor.authorBrockelmann, Pen
dc.contributor.authorIllidge, Timothy Men
dc.date.accessioned2017-05-24T14:25:55Z-
dc.date.available2017-05-24T14:25:55Z-
dc.date.issued2017-05-24-
dc.identifier.citationReal-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation. 2016, 101(s5): 51 Haematologicaen
dc.identifier.urihttp://hdl.handle.net/10541/620390-
dc.language.isoenen
dc.titleReal-world effectiveness of brentuximab vedotin vs other treatments in patients with relapsed/refractory hodgkin lymphoma post autologous stem-cell transplantation.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentMillennium Pharmaceuticals, Inc., Cambridge, MA, USAen
dc.identifier.journalHaematologicaen
dc.description.collectionLymphoma Research Teamen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.